Frontline Excellence in Ambulatory Chronic Disease Management Modules

Wednesday, November 11, 2020, 6:00 PM - 7:30 PM EST, Online


The goal of this CME activity is to provide physicians and their clinical staff education on how to successfully manage chronic disease in the ambulatory setting, following best practices for classification, medication management, and multi-disciplinary collaboration.

1. Outline optimal ambulatory management and medication considerations for Diabetes Mellitus (DM) type II and Heart Failure (HF)
2. Recognize value of multidisciplinary teamwork to optimize disease management for Diabetes Mellitus (DM) type II and Heart Failure (HF)
3. Understand management consideration for HF sub-types (HFREF, HFPEF, RHF).
4. Outline appropriate usage and considerations for diabetic medications including SGLT2 inhibitors and DPP-4 inhibitors

This activity is complimentary.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Verification of Attendance
Verification of attendance will be provided to all professionals.

Special Needs
The Icahn School of Medicine at Mount Sinai is in full compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special needs or accommodations please contact the Page and William Black Post-Graduate School of Medicine at [email protected].

AMA PRA Category 1 Credits™ (1.50 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Wednesday, November 11, 2020